Introduction: Advancing Drug Discovery for Alzheimer's Disease [ ISOA Fifth Annual Investigators Meeting “Recent Advances in Drug Discovery and Development for Alzheimer's Disease” Sponsored by Elan Pharmaceuticals Inc, The Graphic Expression, Glaxo Smith Kline
Pharmaceuticals, Neurochem Inc, Pfizer Inc. (Guest Editors: Howard M. Fillit and Lorenzo M. Refolo)]

Introduction: Advancing Drug Discovery for Alzheimer's Disease [ ISOA Fifth Annual Investigators Meeting “Recent Advances in Drug Discovery and Development for Alzheimer's Disease” Sponsored by Elan Pharmaceuticals Inc, The Graphic Expression, Glaxo Smith Kline Pharmaceuticals, Neurochem Inc, Pfizer Inc. (Guest Editors: Howard M. Fillit and Lorenzo M. Refolo)]
Authors: Howard M. Fillit¹ and Lorenzo M. Refolo²
View Affiliations Hide Affiliations

¹ The Institute for the Study of Aging, 1414 Avenue of the Americas, Suite 1502, New York, NY, USA ² The Institute for the Study of Aging, 1414 Avenue of the Americas, Suite 1502, New York, NY, USA
Source: Current Alzheimer Research, Volume 2, Issue 2, Apr 2005, p. 105 - 107
DOI: https://doi.org/10.2174/1567205053585729
- Available online: 01 Apr 2005

There is no abstract available.

Article metrics loading...

/content/journals/car/10.2174/1567205053585729

2005-04-01

2025-09-10

Full text loading...

/content/journals/car/10.2174/1567205053585729

Most Cited Most Cited RSS feed